OCS Announces New Supply Agreements with Additional Licensed Producers and Accessory Suppliers

The Ontario Cannabis Store (OCS) is dedicated to providing safe and responsible access to recreational cannabis through its online store once it’s legal on October 17.  In preparation for October, the OCS has been establishing its wholesale distribution network so they can provide a broad selection of cannabis products in their legal and privately run stores once Ontario puts its regulations in place.

This week the OCS announced that they have signed six more agreements with licensed producers, bringing their total to 32 licensed producers and 10 accessory suppliers. Of the licensed producers signed, MediPharm Labs Inc. was one of them. MediPharm Labs is a leading B2B Canadian cannabis extractor that produces pharma-grade cannabis oil and concentrates for cannabinoid derived products. Their state-of-the-art facility can currently process 100,000 kilograms of dry cannabis per year and the company plans on increasing its capacity to over 250,000 kilograms per year by Q4 2018. MediPharm Labs has secured a steady supply of cannabis to process from several licensed producers including the James E. Wagner Cultivation Corporation (TSXV:JWCA) and 6779264 Manitoba Ltd. (O/A Bonify).

The OCS also signed the following licensed producers and accessory suppliers: WeedMD Rx Inc. (TSXV:WMD), Canna Farms Ltd., United Greeneries Ltd., Emerald Health Therapeutics Canada, Agrima Botanicals Corp., Crown Cannabis Canada, Maqabim Distributors Ltd., Hiku Brands Company Ltd. (recently acquired by Canopy Growth (TSX:WEED)), Famous Brandz Inc., Aurora Cannabis (TSX:ACB), Cannavolve Inc., Greenlane, The Twelve Barrels Spirits Co., HBI Canada and Humble+Fume.

To view the full article, click here.

Click here to connect with MediPharm Labs for an Investor Presentation.

The post OCS Announces New Supply Agreements with Additional Licensed Producers and Accessory Suppliers appeared first on Investing News Network.

Investing News Network

, , , , , , ,

Comments are closed.